Abstract:Abstract Prostate cancer (PCa) is a leading cause of death by cancer in men, resulting in approximately 32,000 deaths each year. While the cause of PCa is not clearly known at this time, some risk factors include age, diet, race, and activation of certain oncogenes. Hepatoma-derived growth factor (HDGF) is a recently discovered oncogene and a key mitogenic growth factor which is activated in lung, liver, and skin cancers, however, its role in the development of PCa is unknown. Therefore, the goal of this study is to characterize the role of HDGF in prostate carcinogenesis. A normal prostate cell line, RWPE-1, and four different PCa cell lines, LNCaP, 22RV1, DU145, and PC-3, were analyzed for their expression level of HDGF by western blot analysis. Results of this evaluation revealed that HDGF is over-expressed in multiple PCa cell lines while minimally expressed in RWPE-1 cells. When the HDGF gene is ectopically over-expressed in normal RWPE-1 cells, proliferative rate was increased by 1.5 fold compared to the normal cells, suggesting that HDGF has growth stimulating activity. On the contrary, down regulation of HDGF expression by siRNA significantly inhibited the survival of both androgen dependent (LNCaP) and androgen independent (PC-3) PCa cells. DNA content analysis of RWPE-1 cells stably expressing HDGF by flow cytometry showed that the majority of the cells were in the G2/M phase (55%) of the cell cycle while only 28% of the control RWPE-1 cells were at G2/M phase implying HDGF may have a mitotic function in prostate cells. Furthermore, AKT (phosphorylated form) and NFκB (p65 domain) signaling molecules were found to be activated in RWPE-1 cells expressing HDGF. This activation resulted in the increase of anti-apoptotic molecules Cyclin-E and BCL-2 and the simultaneous decrease in the pro-apoptotic molecule Bax. Activation of AKT-NFκB pathway plays a vital role in the carcinogenesis of several cancers, including PCa. Thus, HDGF over-expression may play a role in regulating this survival pathway in prostate carcinogenesis. Collectively, the results of this study suggest that HDGF is a key player in the development of PCa and may serve as a target for chemopreventive or chemotherapeutic strategies in PCa. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1109. doi:10.1158/1538-7445.AM2011-1109

Hepatoma-Derived Growth Factor Expression and Its Clinical Significance in Breast Cancer

Relationship of HDGF or VEGF expression with hepatocellular carcinoma angiogenesis:report of 108 cases

Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.

Prognostic role of hepatoma-derived growth factor in solid tumors of Eastern Asia: a systematic review and meta- analysis.

The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome

Various Effects of Hepatoma-Derived Growth Factor on Cell Growth, Migration and Invasion of Breast Cancer and Prostate Cancer Cells.

Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas.

Expression Of Fgf19/Fgfr4 Related Biomarkers In Hepatocellular Carcinoma

Clinical and Biological Significance of Hepatoma-Derived Growth Factor in Ewing's Sarcoma.

Expression of Hepatoma-Derived Growth Factor and Cyclin D1 in Human Glioma Tissues and Their Clinical Significances

Cmar_a_215341 7909..7923

Upregulation of Nucleus HDGF Predicts Poor Prognostic Outcome in Patients with Penile Squamous Cell Carcinoma Bypass VEGF-A and Ki-67

Expression of HGF in gastric carcinoma and the correlation with lymphangiogenesis and lymph node metastasis

Coexpression of PDGFR-Alpha, PDGFR-Beta and VEGF As a Prognostic Factor in Patients with Hepatocellular Carcinoma

Expression and clinical significance of hepatocyte growth factor receptor and epidermal growth factor receptor in pancreatic cancer

Abstract 1109: Characterization of Hepatoma-Derived Growth Factor (HDGF) As a Novel Survival Related Protein in Prostate Cancer Cells

Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2

Expression of Hypoxia Inducing Factor 1 Alpha and Its Relationships with Proliferating Cell Nuclear Antigen and Microvessel Density in Human Breast Cancer

Downregulation of HDGF Inhibits the Tumorigenesis of Bladder Cancer Cells by Inactivating the PI3K-AKT Signaling Pathway.

The expression of PDGFRα in HCC and association with prognosis

Expression of heat shock factor 1 and its relation with prognosis in breast cancer patients